-+ 0.00%
-+ 0.00%
-+ 0.00%

Sanofi Q3 Attributable Net Income, Net Sales Rise

MT Newswires·10/30/2026 03:08:34
Listen to the news
03:08 AM EDT, 10/30/2026 (MT Newswires) -- Sanofi (SAN.PA) logged 3.02 billion euros in net income attributable to equity holders for the third quarter, compared with 2.80 billion euros a year ago. Basic EPS moved to 2.52 euros from 2.30 euros year over year, a Friday filing showed. For the three months ended Sept. 30, net sales were 14.44 billion euros versus 12.43 billion euros previously, the French pharmaceutical company added. Looking ahead, the company raised its full-year 2026 sales outlook to a low-teens percentage growth at constant exchange rates, compared with 10% growth previously. Business EPS is expected to grow by a mid-teens percentage at constant exchange rates, compared with the previous guidance of slightly faster growth than sales.